Analyst Ratings For Neurotrope (NASDAQ:NTRP)
Today, Roth Capital initiated coverage on Neurotrope (NASDAQ:NTRP) with a Buy with a price target of $15.00.
Some recent analyst ratings include
- 3/8/2018-Roth Capital initiated coverage with a Buy rating.
- 5/2/2017-Aegis Reiterated Rating of Buy.
Recent Insider Trading Activity For Neurotrope (NASDAQ:NTRP)
Neurotrope (NASDAQ:NTRP) has insider ownership of 9.45% and institutional ownership of 14.00%.
- On 12/2/2016 Bruce Bernstein, Director, bought 50,000 with an average share price of $0.28 per share and the total transaction amounting to $14,000.00.
- On 11/23/2016 Kenneth J Gorelick, Director, bought 5,000 with an average share price of $0.29 per share and the total transaction amounting to $1,450.00.
- On 8/26/2016 Kenneth J Gorelick, Director, bought 5,000 with an average share price of $0.41 per share and the total transaction amounting to $2,050.00.
- On 11/23/2015 James Gottlieb, Director, bought 10,000 with an average share price of $0.59 per share and the total transaction amounting to $5,900.00.
Recent Trading Activity for Neurotrope (NASDAQ:NTRP)
Shares of Neurotrope closed the previous trading session at 8.94 up +0.36 4.25% with 8.760000228881836 shares trading hands.
